Estimates of the differencing parameter, d, in Eq (1). by Luis Alberiko Gil-Alana (14659817)

Subjects:

Estimates of the differencing parameter, d, in Eq (1). by Luis Alberiko Gil-Alana (14659817)

Subjects:

Estimated prevalence (A), DALYs (B), and mortality (C) rates for IBD among WCBA by 2040. by Jiefeng Zhao (9090305)

Subjects:

Estimated coefficients based on the selected model in Table 4. by Luis Alberiko Gil-Alana (14659817)

Subjects:

Estimated coefficients based on the selected model in Table 3. by Luis Alberiko Gil-Alana (14659817)

Subjects:

Estimated prevalence (A), DALYs (B), and mortality (C) rates of IBD in different age subgroups of WCBA by 2040. by Jiefeng Zhao (9090305)

Subjects:

Decrease of cellular cAMP levels in response to a concentration range of melatonin treatments. by Cathryn S. D. Maienza (20629929)

Forest plot for the significant MR association between four mediators and anti-H. pylori IgG seropositivity. by Jing Wang (6206297)

Subjects:

Study characteristics and estimates of <i>Giardia</i> infection prevalence associations. Statistically significant values are bolded. by Kareem Hatam-Nahavandi (7384790)

Subjects:

Models 7 to 12: estimation results. by Sakar Hasan Hamza (20978818)

Subjects:

Models 1 to 6: estimation results. by Sakar Hasan Hamza (20978818)

Subjects:

Spearman correlations between the age of the sample donor (20–70 years) and estimated proportions of neuronal, glial, and endothelial cells. by Arttu Autio-Kimura (20454681)

Subjects:

Scatter plot for the significant Mendelian randomization (MR) association (P < 0.05) between mediators and anti-H. pylori IgG seropositivity. by Jing Wang (6206297)

Subjects:

Maximum IFN concentrations are decreased in severe patients. by Sonia T. Gazeau (21512764)

<i>Elsholtzia ciliata</i> extract (ECE) treatment decreases coronavirus-induced plaque formation. by Siyun Lee (17087351)

“…<b>(B)</b> ECE treatment decreases plaque formation in a dose-dependent manner. …”

Average ratio of the concentrations obtained with qPCR, before and after DNase treatment, and with DAO before DNase treatment of the ISP phage stocks. by Saar Van Overfelt (20378458)

Subjects:

Average concentration of the ISP phage stocks obtained with qPCR, before and after DNase treatment, and with the DAO method before the DNase treatment. by Saar Van Overfelt (20378458)

Subjects:

Visualization of DNA in an untreated ISP phage stock by immunogold labelling. by Saar Van Overfelt (20378458)

Subjects:

Experimental set up to determine the impact of DNase treatment of ISP phage stocks with different storage periods (ISP-1, ISP-2 and ISP-3) on the quantification with qPCR and the a... by Saar Van Overfelt (20378458)

Subjects:

General linear mixed model coefficients and significance for species-specific ungulate intensity of use as a function of cattle grazing period. by Kathryn Knodel (20036529)